New drug combo aims to stop liver cancer from coming back after ablation
NCT ID NCT04727307
First seen Nov 01, 2025 · Last updated May 26, 2026 · Updated 30 times
Summary
This study tests whether adding the drugs atezolizumab and bevacizumab before and after standard radiofrequency ablation can lower the chance of liver cancer returning. About 202 adults with small liver tumors (less than 3 cm) will be randomly assigned to ablation alone or ablation plus the drug combo. The goal is to see if the combo improves recurrence-free survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH Perpignan
RECRUITINGPerpignan, France
Contact
Contact
-
CHRU de Nancy
RECRUITINGNancy, France
Contact
Contact
-
CHU Amiens
RECRUITINGAmiens, France
Contact
Contact
-
CHU Dijon
RECRUITINGDijon, France
Contact
Contact
-
CHU Nîmes
RECRUITINGNîmes, France
Contact
Contact
-
CHU d'Angers
RECRUITINGAngers, France
Contact
Contact
-
CHU de Grenoble
RECRUITINGGrenoble, France
Contact
Contact
-
CHU de Lille
NOT_YET_RECRUITINGLille, France
Contact
Contact
-
CHU de Montpellier
RECRUITINGMontpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nantes
RECRUITINGNantes, France
Contact
Contact
-
CHU de Nice
NOT_YET_RECRUITINGNice, France
Contact
Contact
-
CHU de Poitiers
RECRUITINGPoitiers, France
Contact
Contact
-
CHU de Rennes
RECRUITINGRennes, France
Contact
Contact
-
Centre Georges François Leclerc
RECRUITINGDijon, France
Contact
Contact
-
Hôpital Beaujon
RECRUITINGClichy, France
Contact
Contact
-
Hôpital Cochin
RECRUITINGParis, France
Contact
Contact
-
Hôpital Jean Verdier
RECRUITINGBondy, France
Contact
Contact
-
Hôpital Saint Joseph
RECRUITINGMarseille, France
Contact
Contact
-
Institut Gustave Roussy
RECRUITINGVillejuif, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.